Top Markets
#1 aelf aelf +14.51%
#2 Status Status +10.16%
#3 TDCCP TDCCP +8.49%
#4 Cryptopia Cryptopia +6.56%
#5 Tutorial Tutorial +6.19%
#6 DAPPOS DAPPOS +5.63%
#7 HOME HOME +4.84%
#8 Nillion Nillion +4.45%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +4.43%
#10 Mina Protocol Mina Protocol +4.40%
Coin of the day
aelf aelf
Settings
Language
ENGLISH
Currency
USD
Theme
Viyash Scientific Limited Viyash Scientific Limited

Viyash Scientific Limited

VIYASH
Rank in Stocks #8355
Viyash Scientific Limited is a global veterinary healthcare company with... Viyash Scientific Limited is a global veterinary healthcare company with operations spanning Europe, Asia, and other international markets. It specializes in developing and supplying finished dosage forms for a range of therapeutic applications, including nutritional support, pain relief, parasite control, antibiotic treatments, and gut health solutions. These products cater to various animals like livestock, poultry, and domestic pets. Additionally, the company extends its expertise through analytical testing and specialized veterinary formulation services. Originally established as Sequent Scientific Limited, the company officially adopted the name Viyash Scientific Limited in January 2026. Founded in 1985, its corporate headquarters are situated in Hyderabad, India. Currently, Viyash Scientific Limited functions as a subsidiary of CA Harbor Investments.
Share Price
$2.95
Last synced: 2026-08-28
Market Cap
$1.29B
Change (1 day)
3.04%
Change (1 year)
53.62%
Country
IN
Trade Viyash Scientific Limited (VIYASH)

Category

Healthcare
P/E ratio for Viyash Scientific Limited (VIYASH)
P/E ratio as of 2026 TTM: 0
According to Viyash Scientific Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Viyash Scientific Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.